Palatin Technologies Soars 111.52% Amid Delisting Fears, Retail Interest

On April 14, 2025, Palatin Technologies experienced a remarkable surge, with its stock price soaring by 111.52% in pre-market trading.

Palatin Technologies is currently facing a potential delisting from the NYSE American. The company has received a notice from the NYSE Listings Qualifications Panel, which will ultimately decide whether Palatin's stock will remain listed or be delisted. Palatin is actively working to address the issues raised by the NYSE.

Retail investors have shown significant interest in Palatin Technologies, with a 600% increase in weekly message volume on social media platforms. This surge in interest comes as the company navigates the potential delisting from the NYSE American.

Palatin Technologies recently announced positive data from the Phase 2b BREAKOUT study of a melanocortin agonist in patients with diabetic Type 2. This development highlights the company's ongoing efforts in the biopharmaceutical sector, focusing on targeted receptor-specific therapeutics for various diseases.